The continued climb of the U.S. dollar weighed heavily on pharmaceutical giant Johnson & Johnson’s first quarter earnings reported Tuesday morning. It was in many ways a repeat of a […]

The U.S. Senate, following last month’s bipartisan action by the U.S. House of Representatives, tonight overwhelmingly passed a repeal of Medicare’s controversial sustainable growth rate formula. The vote, by a […]

Italian billionaire Stefano Pessina wasn’t ready this week to say Walgreens Boots Alliance (WBA) was prepared to buy Rite Aid (RAD), but he said more government influence on payments to […]

April 14, 2015By Riley McDermid, Breaking News Sr. Editor The American biotech sector will see a continued boom in its merger and acquisition cycle after an unprecedented first quarter […]

April 14, 2015By Alex Keown, Breaking News Staff MELVILLE, N.Y.– BioRestorative Therapies, Inc. a life sciences company developing adult stem cell-based therapies for various medical applications, moved its corporate […]

April 14, 2015By Mark Terry, Breaking News Staff Kenilworth, N.J.-based Merck & Co. (MRK)’s recent Securities and Exchange Commission (SEC) filings indicate that CEO Kenneth Frazier will see an […]

April 14, 2015By Krystle Vermes, Breaking News Staff Delaware-based Incyte Corporation (INCY), an oncology-focused biopharmaceutical company, announced on April 14 that it will be establishing a European headquarters in […]

NEW YORK, April 14, 2015 /PRNewswire/ — The CementBloc has announced the addition of Robin Tzannes, Sharon Howard-Butler, and Marc Law to its creative leadership team. Photo –  Sharon Howard-Butler […]

Antigen-Specific Immunotherapy to Potentially Prevent or Delay Diabetes in Preclinical Model TOKYO, JAPAN–(Marketwired – Apr 14, 2015) – REGiMMUNE Corporation (RGI) and JDRF today announced a partnership, along with financial […]

April 14, 2015By Riley McDermid, Breaking News Sr. Editor Bankers are leaving their jobs at large investment firms for smaller, boutique outfits in a bid to get a piece […]